Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.58M Sell
20,880
-5,951
-22% -$640K ﹤0.01% 2455
2026
Q1
$2.75M Buy
26,831
+1,311
+5% +$134K ﹤0.01% 2139
2025
Q4
$2.57M Sell
25,520
-2,145
-8% -$212K ﹤0.01% 1975
2025
Q3
$2.39M Sell
27,665
-6,049
-18% -$478K ﹤0.01% 1875
2025
Q2
$2.57M Buy
33,714
+23,840
+241% +$1.74M ﹤0.01% 1636
2025
Q1
$700K Buy
9,874
+3,881
+65% +$303K ﹤0.01% 2236
2024
Q4
$469K Sell
5,993
-3,255
-35% -$304K ﹤0.01% 2286
2024
Q3
$946K Sell
9,248
-4,116
-31% -$341K ﹤0.01% 1881
2024
Q2
$1.01M Sell
13,364
-8,783
-40% -$625K ﹤0.01% 1747
2024
Q1
$1.66M Buy
22,147
+13,315
+151% +$1.06M ﹤0.01% 1482
2023
Q4
$650K Sell
8,832
-427
-5% -$26.4K ﹤0.01% 1768
2023
Q3
$426K Buy
9,259
+18
+0.2% +$799 ﹤0.01% 1903
2023
Q2
$390K Buy
+9,241
New +$349K ﹤0.01% 1854

Other funds holding NUVL

Cliff Asness's NUVL Position: Q2 2026 in Review

Cliff Asness reduced its Nuvalent (NUVL) stake by 22% in Q2 2026, selling an estimated $640K and leaving 20,880 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #2455.

Cliff Asness first reported a position in NUVL in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.75M in Q1 2026. 287 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Cliff Asness held 20,880 shares of Nuvalent worth $2.58M as of Q2 2026.
  • Cliff Asness sold 5,951 Nuvalent shares in Q2 2026, an estimated $640K.
  • Nuvalent made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2455 holding.
  • Cliff Asness first reported a position in Nuvalent in Q2 2023 and has held it in 13 quarters since.
  • Cliff Asness's Nuvalent position peaked at $2.75M in Q1 2026.
  • 287 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.